Key takeaways
- Most synthetic peptides are isolated as trifluoroacetate (TFA) salts because TFA is used both in cleavage from the resin and in reversed-phase purification.
- Each protonated basic site (N-terminal amine, Arg, Lys, His) can carry a counter-ion, so counter-ions can make up a substantial share of the weighed mass.
- Acetate and chloride forms are produced by ion exchange or by repeated lyophilization from a different acid, and each method has trade-offs.
- Counter-ion identity can matter for spectroscopy, LC-MS sensitivity, pH of unbuffered solutions and cell-based assays.
- Read the salt form, counter-ion content and net peptide content together; the molecular weight on a COA usually refers to the free peptide.
Peptide counter-ions are the anions that balance the positive charges on a synthetic peptide's basic groups. They are not impurities in the usual sense, but they contribute real mass to the solid and can influence analytical and in vitro experiments. This article explains where trifluoroacetate comes from, how acetate and hydrochloride forms are made, and how the salt form is reported on documentation.
Why synthetic peptides are TFA salts
Trifluoroacetic acid enters the process at two points. In Fmoc-based synthesis, the finished peptide is cleaved from the resin and its side-chain protecting groups are removed with a cocktail that is mostly TFA. Our overview of solid-phase peptide synthesis describes this step. The crude peptide is then purified by reversed-phase HPLC using water and acetonitrile containing around 0.1% TFA, which acts as an ion-pairing agent and gives sharp, well-resolved peaks.
TFA is a strong acid (pKa around 0.2–0.5) and fully protonates the N-terminal amine and the side chains of arginine, lysine and histidine. During lyophilization, unbound TFA is largely removed because it is volatile (boiling point about 72 °C), but trifluoroacetate held as an ion pair with protonated groups remains in the solid.
How many counter-ions?
The maximum number of counter-ions is roughly the number of positively charged groups at low pH, minus any internal salt bridges with acidic residues. In practice the stoichiometry is often non-integer and varies from lot to lot, which is why it is measured rather than assumed.
Common peptide counter-ions compared
| Salt form | Acid (MW, Da) | How it is obtained | Practical notes |
|---|---|---|---|
| Trifluoroacetate | CF3COOH (114.02) | Default from TFA cleavage and RP-HPLC purification | Heaviest of the three; strong IR band near 1670 cm⁻¹; suppresses ESI signal in LC-MS |
| Acetate | CH3COOH (60.05) | Anion-exchange resin in acetate form, or RP-HPLC with acetic acid–based mobile phases | Weak acid; solutions are less acidic; acetic acid is volatile, so stoichiometry can drift during drying |
| Hydrochloride | HCl (36.46) | Repeated dissolution in dilute HCl and lyophilization, or anion exchange in chloride form | Lightest counter-ion; low pH during exchange can affect acid-sensitive sequences |
How counter-ions are exchanged
Lyophilization from a stronger or more volatile acid
For conversion to the hydrochloride, the peptide is dissolved in dilute aqueous HCl and lyophilized, and the process is repeated several times. Each pass displaces part of the trifluoroacetate, which leaves as volatile TFA. The approach is simple, but exchange may be incomplete after a few repetitions and the acidic conditions may not suit every sequence.
Ion-exchange resins
A strong anion-exchange resin loaded with acetate or chloride swaps the counter-ion when the peptide solution passes through it. This can achieve near-complete exchange but adds handling steps, a risk of losing material on the resin and the need to verify that the resin did not introduce other contaminants.
Chromatographic exchange
The peptide can be loaded on a reversed-phase column, washed with a buffer containing the new counter-ion, such as acetic acid or ammonium acetate, and eluted in that system. This combines exchange with a final purification step, although retention and peak shape typically differ from the TFA method.
How counter-ions affect mass and calculations
Counter-ions do not change the molecular weight of the peptide itself, but they increase the formula weight of the solid. For a model peptide with three basic sites and an average molecular weight of 1046.18 Da, a full set of three trifluoroacetates adds 342 Da, so only about 75% of the solid is peptide before water is considered. The equivalent acetate and chloride forms would be about 85% and 90% peptide. The full calculation is shown in our guide to peptide molecular weight calculation.
Converting counter-ion content to a molar ratio
COAs often report counter-ion content as % w/w, measured by ion chromatography, 19F NMR or HPLC with a universal detector. Combined with net peptide content, this gives the counter-ion stoichiometry. For example, with trifluoroacetate content of 18.0% w/w (as the anion, 113.02 g/mol) and an NPC of 75.0%:
- Trifluoroacetate: 0.180 g ÷ 113.02 g/mol = 1.59 mmol per gram of solid
- Peptide: 0.750 g ÷ 1046.18 g/mol = 0.717 mmol per gram of solid
- Ratio: 1.59 ÷ 0.717 ≈ 2.2 trifluoroacetates per peptide
Whether a laboratory reports the anion or the free acid changes the result by about 1%, so the basis should be stated. The relationship between these values is explained further in net peptide content vs. purity.
Effects on assays and cell-based work
Because counter-ions travel with the peptide into every solution, they can influence downstream measurements:
- pH of unbuffered solutions. Dissolving a TFA salt in water gives an acidic solution. Using an adequately buffered solvent and checking the final pH reduces this variable.
- Infrared and circular dichroism spectroscopy. Trifluoroacetate absorbs strongly near 1670 cm⁻¹, overlapping the amide I region used for secondary-structure analysis, so acetate or chloride forms, or deuterated solvents with careful background subtraction, are often chosen for FTIR work.
- LC-MS sensitivity. TFA forms strong ion pairs that suppress electrospray ionization. Formic acid is generally preferred in LC-MS mobile phases, although residual TFA from the sample itself is usually a minor effect at analytical loads.
- Cell-based assays. Counter-ion identity is a recognized variable in cell culture experiments, so many researchers specify an acetate or chloride form for such work and keep the salt form constant across a study.
The practical rule is consistency: comparing results from a TFA lot with results from an acetate lot introduces a variable that has nothing to do with the sequence.
Reading the salt form on documentation
When reviewing a specification or certificate of analysis, look for these items:
- Salt form, stated as TFA salt, acetate salt or hydrochloride, separately from the sequence.
- Molecular weight basis. Most documents report the free peptide; some give the formula weight of an idealized salt, which should be labeled as such.
- Counter-ion content in % w/w with the method used.
- Net peptide content, which reflects counter-ions and water together.
If a document lists only "TFA salt" without a measured content, the counter-ion stoichiometry is unknown, and calculations that assume full salt formation should be regarded as estimates.
Frequently asked questions
Is residual TFA an impurity?
Trifluoroacetate bound as a counter-ion is part of the salt form rather than a process impurity, but it is still a non-peptide component that should be quantified and reported.
Can all trifluoroacetate be removed?
Exchange can reduce it to low levels, but complete removal is difficult to demonstrate. Documentation for exchanged lots often reports a residual TFA limit.
Does the salt form change the HPLC purity?
Not directly, because counter-ions are not integrated as peptide peaks. Retention time and peak shape can change if the sample's counter-ion differs from the mobile phase additive.
Which counter-ion is best?
There is no universal choice. TFA salts are the most common and well characterized; acetate and chloride are often selected for spectroscopy or cell-based assays.
Disclaimer. This article is for research and educational purposes only. It describes laboratory and analytical practice and is not medical advice. It contains no dosing, administration or human-use guidance. Veridryx products are sold for laboratory research use only and are not for human or veterinary use.
References
- USP <1065> Ion Chromatography.
- USP <621> Chromatography.
- Chan, W. C.; White, P. D. (eds.). Fmoc Solid Phase Peptide Synthesis: A Practical Approach. Oxford University Press.